SCHEMBL2167334

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL2167340	1.00	LMNA (0.41)	LMNAPOLA1F7F3CNR1
	SCHEMBL2168058	1.00	LMNA (0.41)	LMNAPOLA1F7F3CNR1
	SCHEMBL3680011	0.86	LMNA (0.58)	LMNAF7F3ALDH1A1TSHR
	SCHEMBL3680013	0.86	LMNA (0.58)	LMNAF7F3ALDH1A1TSHR
	SCHEMBL15977318	0.83	LMNA (0.38)	LMNAF7F3CNR1CNR2
	SCHEMBL6438607	0.83	LMNA (0.45)	LMNAPOLA1ALDH1A1
	SCHEMBL6438604	0.83	LMNA (0.45)	LMNAPOLA1ALDH1A1
	SCHEMBL3678027	0.81	F7 (0.42)	LMNAF7F3ALDH1A1CYP1A2
	SCHEMBL3678023	0.81	F7 (0.42)	LMNAF7F3ALDH1A1CYP1A2
	SCHEMBL15977303	0.81	F7 (0.38)	LMNAF7F3CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.